MSLN positivity (expression in ≥ 5% tumour) was associated with a reduced hazard ratio, but this did not reach statistical significance (P = 0.114, HR = 0.587, 95% CI = 0.3025–1.139). This evidence concerns the gene MSLN and neoplasm.